Refine by
Automatic Synthesis Services
5 services found
Manufactured by:Molecule One sp. z o.o. based inWarszawa (Polska), POLAND
When all components of the M1 platform are deployed, along with a proprietary dataset, your entire discovery pipeline benefits. You may generate millions of compounds with high estimated synthetic accessibility, reduce reaction failure rates at the bench or automate your synthesis workflows. That enables your team to focus on more crucial discovery tasks. We can help you build a pipeline where ...
Manufactured by:ABX Advanced Biochemical Compounds GmbH based inRadeberg, GERMANY
ABX Advanced Biochemical Compounds specializes in the development of radiochemical labelling processes, taking your lead compound from initial concept to a robust and GMP-compliant automated synthesis process. The focus is on finding optimal radiochemical labelling conditions using various radionuclides such as F-18, Ga-68, Lu-177, and I-123. This development involves meticulous purification and ...
by:Strateos Inc. based inMenlo Park, CALIFORNIA (USA)
Hit optimization is a critical step in drug discovery to funnel into lead optimization. Select the most promising hits and leverage H2L, and automated chemical synthesis workflows for faster experimental screening cycles, decreased duration and hands on time, reducing the overall drug discovery timeline leading to promising preclinical candidates. Rapid turnaround of assay data on new small ...
by:JADBio based inLos Angeles, CALIFORNIA (USA)
If you look up Wikipedia, you’ll read Automated machine learning (AutoML) is the process of automating the process of applying machine learning to real-world problems. AutoML covers the complete pipeline from the raw dataset to the deployable machine learning model. AutoML was proposed as an artificial intelligence-based solution to the ever-growing challenge of applying machine learning. ...
Manufactured by:Invicro, LLC based inNeedham, MASSACHUSETTS (USA)
Our radiochemistry team has successfully radiolabeled over 300 biological agents, 500 small molecules and submitted 80 INDs for clinical use of novel radiotracers. This wide range of chemical entities has included CNS-penetrant small molecules, monoclonal antibodies, PSMA-targeted peptides, intrathecally administered molecules, virus and live cell labeling, and heart and blood targeting ...